KLRK1 and breast carcinoma: Roshani et al. observed higher sMICA levels in 49 BC patients compared to healthy subjects, as well as an inverse correlation between sMICA serum levels and NKG2D on NK cells, supporting the aforementioned immune escape mechanisms of breast cancer cells [43].